LOTEFLAM EYE DROPS
Brand:
LOTEFLAM EYE DROPS
Manufacturer:
CIPLA
Manufacturer Details
CIPLA
Compositions:
Loteprednol 0.5% eye drops,
|
Strength
|
Rate
|
Packing Style
|
|
0.5%
|
135.09
|
5ml Eye drops
|
List of Related Indications:
List Of Drugs:
- Loteprednol etabonate - Opthalmic Corticosteroids- (FDC- List )-(March 2002)
Indication Type Description:
Drug Interaction:
Cycloplegics
Indication:
LIST OF DRUGS DURING 2007
Sr.No- 16
Name of the Drug- Loteprednol Etabonate 5mg+
Tobramycin 3mg per ml
Ophthalmic solution
Pharmacological Classification- For steroid responsive inflammatory
Ocular condition
Date of Approval- 14-02-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
LIST OF DRUGS DURING 2007
Sr.No- 108
Name of the Drug- Loteprednol Etabonate (0.5%)+
Levifloxacin (1.5%) Eye drops Pharmacological Classification- For post-operative steroid responsive inflammatory
ocular conditions when ocular bacterial infection
exists
Date of Approval- 12-07-07
Approved by U.S.FDA on 30-12-2007 (Ref- FDA approved List- 2007)
Seasonal allergic conjuntivitis
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Loteprednol etabonate 15-03-2002
Ophthalmic solution
Corticosteroid ,Ophthalmic Anti- Inflammatory
2.Loteprednol Etabonate 0.5% 12-07-2007
+ Levofloxacin 1.5% eye drops
For post-operative responsive inflammatory ocular conditions when
ocular bacterial infections or a risk of bacerial infection exists
3.Loteprednol Etabonate 0.5% w/v 01-12-2009
+ Moxifloxacin 0.5% w/v
ophthalmic suspension
For the treatment of post operative steroid responsive inflammatory
ocular infections or risk f bacterial ocular infections exists
4.Loteprednol Etabonate 5mg 14-02-2007
+ Tobramycin 3mg/ml ophthalmic
solution
For steroid responsive inflammatory ocular condition
5. Loteprednol Etabonate 31-01-2009
Nasal spray 0.1%w/v
For prophylaxis and treatment of nasal symptoms of seasonal rhinitis
Adverse Reaction:
Local reactions ( eg. blurred vision, buring, itching, dry eye ) Photobhobia, headache, rhinitis, pharyngitis, May mask or exacerbate ocular infections. Prolonged use may increase IOP , optic nerve damage, visual acuity and field defects, cataract formation, corneal perforation Foreign body sensation, epiphoria, corneal defect, conjuntival hyperaemia
Contra-Indications:
Fungal, viral, mycobacterial amoebic or purulent infections of cornea and conjuvtiva Undiagnosed red eye, Lactation Special precations- Re-evaluate if no improvement after 2 days. Precscribe initially and review after 14 days onlt after appropiate exam. Corneal or scleral thinning Glaucoma History of hepes simplex Monitor IOP and for secondary infections inprolonge therapy ( > 10 days ) Avoid abrupt cassation Soft lens ( remove, may insert after 15 minutes after instillation ) Prolonged use Pregnancy
Dosages/ Overdosage Etc:
Indication-
Seasonal allergic conjuntivitis
Dosage-
1 drop into affected eye(s) 4 times a day Children - not recommened
Other Information:
Seasonal allergic conjuntivitis
Pregnancy and lactation:
Use contraindicated Observe caution and use only if needed
